AARS1 is significantly overexpressed in gastric cancer (GC) [16], duodenal cancer (DC) [47], and many other types of cancer [15], and it is negatively associated with the survival of gastric cancer [16] and breast cancer patients [15]. Here, AARS1 is linked to breast cancer.